Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up

Circulation: Cardiovascular Interventions

Volumn 6, Issue 1, 2013, Pages 68-76

  Iida, Osamu ^a   Nakamura, Masato ^b   Yamauchi, Yasutaka ^c   Kawasaki, Daizo ^d   Yokoi, Yoshiaki ^e   Yokoi, Hiroyoshi ^f   Soga, Yoshimistu ^f   Zen, Kan ^g   Hirano, Keisuke ^h   Suematsu, Nobuhiro ⁱ   Inoue, Naoto ^j   Suzuki, Kenji ^j   Shintani, Yoshiaki ^f,k   Miyashita, Yusuke ^l   Urasawa, Kazushi ^m   Kitano, Ikuro ⁿ   Yamaoka, Terutoshi ^o   Murakami, Takashi ^p   Uesugi, Michitaka ^q   Tsuchiya, Taketsugu ^r   Shinke, Toshiro ^s   Oba, Yasuhiro ^t   Ohura, Norihiko ^u   Hamasaki, Toshimitsu ^v   Nanto, Shinsuke ^v   more..

^a KANSAI ROSAI HOSPITAL   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^c Department of Internal Medicine   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e Kishiwada Tokushukai Hospital   (Japan)

^f KOKURA MEMORIAL HOSPITAL   (Japan)

^g Omihachiman Community Medical Center   (Japan)

^h SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

ⁱ FUKUOKA RED CROSS HOSPITAL   (Japan)

^j SENDAI KOUSEI HOSPITAL   (Japan)

^k Shin Koga Hospital   (Japan)

^l SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m Tokeidai Memorial Hospital   (Japan)

ⁿ Shinsuma General Hospital   (Japan)

^o MATSUYAMA RED CROSS HOSPITAL   (Japan)

^p KAMEDA MEDICAL CENTER   (Japan)

^q OGAKI MUNICIPAL HOSPITAL   (Japan)

^r KANAZAWA MEDICAL UNIVERSITY   (Japan)

^s KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^t Kasugai Municipal Hospital   (Japan)

^u KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^v OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Below the knee lesion; Critical limb ischemia; Endovascular treatment

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AMPUTATION; AMPUTATION FREE SURVIVAL; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CRITICAL LIMB ISCHEMIA; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART FAILURE; HEMODIALYSIS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; STENT; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; ULCER HEALING; WOUND HEALING; WOUND INFECTION;

AGED; ARTERIES; ENDOVASCULAR PROCEDURES; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INGUINAL CANAL; ISCHEMIA; JAPAN; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 84879157593     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.112.975318     Document Type: Article

References (40)

1. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91:1472-1479.
2. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47:921-929.
3. Critical limb ischaemia: management and outcome. Report of a national survey. Vasc Surg Soc Great Britain Ireland. 1995;10:108-13.
4. Arain SA, White CJ. Endovascular therapy for critical limb ischemia. Vasc Med. 2008;13:267-279.
5. Bailey CM, Saha S, Magee TR, Galland RB. A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia. Eur J Vasc Endovasc Surg. 2003;25:131-134.
6. BASIL participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): Multicentre, randomized controlled trial. Lancet. 2005;366:1925-34.
7. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, Gillespie I, Vaughan Ruckley C, Raab GM on behalf of the BASIL trial Participants: Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51:5S-17S.
8. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, Gillespie I, Vaughan Ruckley C, Raab GM on behalf of the BASIL trial Participants: Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010;51:18S-31S.
9. Schamp KB, Meerwaldt R, Reijnen MM, Geelkerken RH, Zeebregts CJ. The ongoing battle between infrapopliteal angioplasty and bypass surgery for critical limb ischemia. Ann Vasc Surg. 2012;26:1145-1153.
10. Mills JL Sr. Open bypass and endoluminal therapy: complementary techniques for revascularization in diabetic patients with critical limb ischaemia. Diabetes Metab Res Rev. 2008;24(Suppl 1):S34-S39.
11. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, III, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1-75.
12. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-e654.
13. DeRubertis BG, Faries PL, McKinsey JF, Chaer RA, Pierce M, Karwowski J, Weinberg A, Nowygrod R, Morrissey NJ, Bush HL, Kent KC. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg. 2007;246:415-422; discussion 422.
14. Conrad MF, Crawford RS, Hackney LA, Paruchuri V, Abularrage CJ, Patel VI, Lamuraglia GM, Cambria RP. Endovascular management of patients with critical limb ischemia. J Vasc Surg. 2011;53:1020-1025.
15. Rastan A, Brechtel K, Krankenberg H, Zahorsky R, Tepe G, Noory E, Schwarzwälder U, Macharzina R, Schwarz T, Bürgelin K, Sixt S, Tübler T, Neumann FJ, Zeller T. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: longterm results from a randomized trial. J Am Coll Cardiol. 2012;60:587-591.
16. Rutherford RB, Flanigan DP, Gupta, SK, Johnston KW, Karmody A, Whittemore AD, Baker JD, Ernst CB. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1986;4:80-94.
17. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538.
18. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975-981.
19. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Metaanalysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006;43:498-503.
20. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009;50:1462-73, e1.
21. Castronuovo JJ, Jr, Adera HM, Smiell JM, Price RM. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg. 1997;26:629-637.
22. Zhan LX, Bharara M, White M, Bhatnagar S, Lepow B, Armstrong DG, Mills JL, Sr. Comparison of initial hemodynamic response after endovascular therapy and open surgical bypass in patients with diabetes mellitus and critical limb ischemia. J Vasc Surg. 2012;56:380-386; discussion 386.
23. Biancari F, Salenius JP, Heikkinen M, Luther M, Ylönen K, Lepäntalo M. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg. 2007;31:217-225; discussion 226.
24. Khan MU, Lall P, Harris LM, Dryjski ML, Dosluoglu HH. Predictors of limb loss despite a patent endovascular-treated arterial segment. J Vasc Surg. 2009;49:1440-1445; discussion 1445.
25. Conte MS. Understanding objective performance goals for critical limb ischemia trials. Semin Vasc Surg. 2010;23:129-137.
26. Ndip A, Lavery LA, Boulton AJ. Diabetic foot disease in people with advanced nephropathy and those on renal dialysis. Curr Diab Rep. 2010;10:283-290.
27. Galal W, van Gestel YR, Hoeks SE, Sin DD, Winkel TA, Bax JJ, Verhagen H, Awara AM, Klein J, van Domburg RT, Poldermans D. The obesity paradox in patients with peripheral arterial disease. Chest. 2008;134:925-930.
28. Venermo M, Biancari F, Arvela E, Korhonen M, Söderström M, Halmesmäki K, Albäck A, Lepäntalo M. The role of chronic kidney disease as a predictor of outcome after revascularisation of the ulcerated diabetic foot. Diabetologia. 2011;54:2971-2977.
29. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Van Acker K, Van Baal J, Van Merode F, Ferreira I, Huijberts M. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51:747-755.
30. Simsir SA, Cabellon A, Kohlman-Trigoboff D, Smith BM. Factors influencing limb salvage and survival after amputation and revascularization in patients with end-stage renal disease. Am J Surg. 1995;170:113-117.
31. Albers M, Romiti M, De Luccia N, Brochado-Neto FC, Nishimoto I, Pereira CA. An updated meta-analysis of infrainguinal arterial reconstruction in patients with end-stage renal disease. J Vasc Surg. 2007;45:536-542.
32. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
33. Gershater MA, Löndahl M, Nyberg P, Larsson J, Thörne J, Eneroth M, Apelqvist J. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52:398-407.
34. Faglia E, Clerici G, Caminiti M, Quarantiello A, Curci V, Morabito A. Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2007;33:731-736.
35. Virkkunen J, Heikkinen M, Lepäntalo M, Metsänoja R, Salenius JP; Finnvasc Study Group. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg. 2004;40:761-767.
36. Biancari F, Salenius JP, Heikkinen M, Luther M, Ylönen K, Lepäntalo M. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg. 2007;31:217-225; discussion 226.
37. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464-1471.
38. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, Fujita M, Terashi H, Nagata S. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010;75:830-836.
39. Utsunomiya M, Nakamura M, Nakanishi M, Takagi T, Hara H, Onishi K, Yamada T, Sugi K. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg. 2012;55:113-121.
40. Yamada T, Ohta T, Ishibashi H, Sugimoto I, Iwata H, Takahashi M, Kawanishi J. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs-comparison with other noninvasive diagnostic methods. J Vasc Surg. 2008;47:318-323.